Skip to main content

Table 1 Parasite isolates used in this study

From: The extended recovery ring-stage survival assay provides a superior association with patient clearance half-life and increases throughput

Isolatekelch13 mutationPC1/2LocationYear
NHP1333N458I9.24MKT2011
NHP1455R561H8.02MKT2012
NHP1337C580Y7.83MKT2011
NHP4333C538V7.7WPA2008
NHP4373WT7.1WPA2008
NHP3035M476I6.16MLA2008
NHP4078A675V5.82WPA2008
NHP4201WT5.65WPA2008
NHP4106WT5.54WPA2008
NHP4673E252Q5.34WPA2010
NHP4748WT2.89WPA2011
NHP4072WT2.29WPA2008
NHP3032K438N2.17MLA2008
NHP4302WT1.98WPA2008
NHP1386WT1.67MKT2011
  1. Overview of 15 parasite isolates used in this study. Patient clearance rates were calculated with [5]. Location of isolate collection and year of collection are as reported from Phyo et al. [19], Taylor et al. [28], and Cheeseman et al. [29]. Samples were all collected from clinics on the northwestern border of Thailand
  2. MKT: Mawker Thai, MLA: Maela, and WPA: Wang Pha